In-vitro diagnostic (IVD) tests are intended to perform examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information concerning physiological or pathological state, or concerning congenital abnormality. In-vitro diagnostics accounts for a major share in the global diagnostics market. The global IVD market has been experiencing rapid growth, inspite of the economic recession.
On the basis of technology, clinical biochemistry dominates the global IVD market, followed by immunoassays and molecular biology. Some other segments are expected to register rapid growth in the coming years. On the basis of customer segments, clinical lab is the largest segment followed by point-of-care and research labs. Point-of-care customer segment offers diagnostic services at or near the site of the patient. Glucose monitoring recorded the largest share in the point-of-care segment.
Globally, North America, Europe and Japan are the largest IVD markets. In Europe, the largest markets are Germany, France and Italy. India, China and Brazil are the emerging IVD markets which will register high growth in the coming years.
The main drivers of IVD industry discussed in this report are increasing ageing population, growing diabetic population, high insurance density and low vitamin D penetration. Also, there are some key trends which include significant merger and acquisition activity in the industry. IVD market faces various challenges in the face of stringent regulations.
Global IVD industry is consolidated with the top six players competing for a major share in the market which includes Roche, the market leader, followed by Abbott, Seimens, Johnson and Johnson, Danaher and biomerieux.
The report analyzes the IVD market on a global scale and its various segments and also provides detailed information regarding the key regional market, Europe as well as the emerging economies, India, China and Brazil. It further discusses the various trends and challenges of the global IVD market. It profiles the three major pharmaceutical players involved in IVD testing - Roche Holdings, Siemens AG and Abbott Laboratories.
By combining SPSS Inc.’s data integration and analysis capabilities with our relevant findings, we have predicted the future growth of the industry. We employed various significant variables that have an impact on this industry and created regression models with SPSS Base to determine the future direction of the industry. Before deploying the regression model, the relationship between several independent or predictor variables and the dependent variable was analyzed using standard SPSS output, including charts, tables and tests.